Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Japan. The aim of this study is to collect information about the
efficacy and safety of Norditropin® (somatropin) in the long-term treatment of short stature
with GHD (Growth Hormone Deficiency) where epiphysial discs are not closed and short stature
with Turner Syndrome where epiphysial discs are not closed.